Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held in New York, NY, on Wednesday, June 7, 2023 at 9:30 a.m. ET.
A webcast of Sensei’s presentation will be available in the Investors section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event. Registration for the webcast is available here.
About Sensei Biotherapeutics
Maximizing Cloud to Build and Bundle Service Offerings
ITEXPO, MSP Expo, Future of Work, AstriCon, Generative AI and Enterprise Metaverse Expo Conference Sessions
Lunch - For Diamond, Enterprise, Platinum, Super Pass, Exhibitor/Conference, Speaker, Press Pass Holders